Meeting Presentations

PUBLISHED ABSTRACTS OF CONFERENCES AND SYMPOSIA

• Mukherjee, J., Liang, C., Syed, A.U., Lam, P.Q., Mondal, R., Mukherjee, T., Patel, K.K. Monoamine Oxidase-A is Upregulated in Post-Mortem Human Alzheimer’s Disease and Parkinson’s Disease Brain. Journal of Nuclear Medicine, Vol. 62, Supplement 1, 1609, 2021. Presented at the Annual Society of Nuclear Medicine and Molecular Imaging Meeting, June 13-16, 2021 (Virtual Meeting).

 

•  Kaur, H., Felix, M.R., Nguyen, A.N., Syed, A.U., Liang, C., Mukherjee, J. Evaluation of [¹⁸F]Flotaza, a new b-amyloid PET imaging agent in post-mortem human Alzheimer’s disease brain and 5XFAD transgenic mice. Journal of Nuclear Medicine, Vol. 62, Supplement 1, 1627, 2021. Presented at the Annual Society of Nuclear Medicine and Molecular Imaging Meeting, June 13-16, 2021 (Virtual Meeting).

 

• Syed, A.U., Liang, C., Mukherjee, J. [¹⁸F]Fluoroethylharmol: Improved Radiosynthesis and Evaluation of Monoamine Oxidase-A in Human Alzheimer’s and Parkinson’s Disease. Journal of Nuclear Medicine, Vol. 62, Supplement 1, 1628, 2021. Presented at the Annual Society of Nuclear Medicine and Molecular Imaging Meeting, June 13-16, 2021 (Virtual Meeting).

 

• Campoy, A., Mondal, R., Liang, C., Mukherjee, J. [¹⁸F]FDG PET/CT Studies in Parkinson’s Disease Mouse Model of a-Syncleinopathy. Journal of Nuclear Medicine, Vol. 62, Supplement 1, 1613, 2021. Presented at the Annual Society of Nuclear Medicine and Molecular Imaging Meeting, June 13-16, 2021 (Virtual Meeting).

 

• Liang, C., Campoy, A., Mondal, R., Mukherjee, J. [¹⁸F]Nifene PET/CT Studies in Parkinson’s Disease A53T Mouse Model of a-Syncleinopathy. Journal of Nuclear Medicine, Vol. 62, Supplement 1, 1615, 2021. Presented at the Annual Society of Nuclear Medicine and Molecular Imaging Meeting, June 13-16, 2021 (Virtual Meeting).

 

• Mukherjee, J., Liang, C., Campoy, A., Kaur, H., Syed, A.U., Danh, T.B. Human hippocampal [¹⁸F]nifene binding to nicotinic acetylcholinergic α4β2* receptors is reduced in postmortem Alzheimer’s disease brains. Journal of Nuclear Medicine, Vol. 62, Supplement 1, 121. Presented at the Annual Society of Nuclear Medicine and Molecular Imaging Meeting, June 13-16, 2021 (Virtual Meeting).

• Kaur, H., Felix, M.R., Liang, C., Mukherjee, J. [¹⁸F]Flotaza: A New b-Amyloid PET Imaging Agent in Post-Mortem Human Alzheimer’s Disease Brain. Presented at the World Molecular Imaging Congress 2020, October 7-10, 2020 (Virtual Meeting).

 

• Mondal, R., Liang, C., Campoy, A., Lam, P.Q., Danh, T., Mukherjee, J. PET Studies in Transgenic Hualpha-Syn(A53T) Parkinson’s Disease Mouse Model of a-Syncleinopathy. Presented at the World Molecular Imaging Congress 2020, October 7-10, 2020 (Virtual Meeting).

 

• Liang, C., Lam, P.Q., Mondal, R., Campoy A., Danh, T., Martinez, S., Mukherjee, J. [¹⁸F]FAZIN3: Novel Monoamine Oxidase-A PET Reversible Radiotracer shows Upregulation in Post-Mortem Human Alzheimer’s and Parkinson’s Disease. Presented at the World Molecular Imaging Congress 2020, October 7-10, 2020 (Virtual Meeting).

 

• Mukherjee, J., Liang, C., Patel, K.K., Lam, P.Q., Mondal, R. [¹²⁵I]IPPI for tau imaging in post-mortem human Alzheimer’s disease brain. Presented at the World Molecular Imaging Congress 2020, October 7-10, 2020 (Virtual Meeting).

 

• Mitchell, S., Zhang, H.J., Bhuiyan, M., Tsai, H.M., Leoni, L., Freifelder, R., Roman B., Kao, C-M., Zhuang, X., Green, W., Mukherjee, J., Chen, C.T. Gender differences in binding kinetics of nicotine acetylcholine receptors using microPET/CT with 2-[18F]FA85380. Journal of Nuclear Medicine, Vol. 61, Supplement 1, 82, 2020. Presented at the 67th Annual Meeting of Society of Nuclear Medicine and Molecular Imaging, July 11-14, 2020 (Virtual Meeting).

 

• Campoy, A., Danh, T., Patel, K.K., Kaur, H., Liang, C., Mukherjee J. [¹⁸F]Nifene binding to Nicotinic a4b2*receptors in anterior cingulate of postmortem human Alzheimer’s disease brain. Journal of Nuclear Medicine, Vol. 61, Supplement 1, 1537, 2020. Presented at the 67th Annual Meeting of Society of Nuclear Medicine and Molecular Imaging, July 11-14, 2020 (Virtual Meeting).

 

• Lam, P.Q., Martinez, S., Liang, C., Patel, K.K., Mukherjee J. [¹⁸F]FAZIN3: A novel PET imaging agent for Parkinson’s disease. Journal of Nuclear Medicine, Vol. 61, Supplement 1, 148, 2020. Presented at the 67th Annual Meeting of Society of Nuclear Medicine and Molecular Imaging, July 11-14, 2020 (Virtual Meeting).

 

• Liang, C., Lam, P.Q., Martinez, S., Mukherjee J. Development of [¹⁸F]FAZIN3 for PET imaging of neurofibrillary tangles in Alzheimer’s disease. Journal of Nuclear Medicine, Vol. 61, Supplement 1, 1032, 2020. Presented at the 67th Annual Meeting of Society of Nuclear Medicine and Molecular Imaging, July 11-14, 2020 (Virtual Meeting).

 

• Mitchell, S., Zhang, H.J., Bhuiyan, M., Tsai, H.M., Leoni, L., Freifelder, R., Roman B., Kao, C-M.,Zhuang, X., Green, W., Mukherjee, J., Chen, C.T. Positron emission tomography of 2-[18F]FA85380 binding to nicotinic receptors in female and male mice. To be presented at the Annual Meeting of Society of Neuroscience, Chicago, Illinois, October 22-25, 2019.

 

• Zhang, H.J., Mitchell, S., Tsai, H.M., Bhuiyan, M., Leoni, L., Freifelder, R., Kao, C-M., Zhuang, X., Green, W., Mukherjee, J., Chen, C.T. Investigation of binding kinetics of nicotinic acetylcholine receptors by PET/CT using [18F]fluorine labeled Nifene and 2-Fluoro-3-(2(S)-azetidinylmethoxy)pyridine. Journal of Nuclear Medicine, Vol. 60, Supplement 1, 1310, 2019. Presented at the 66th Annual Meeting of Society of Nuclear Medicine and Molecular Imaging, Anaheim, California, June 22-25, 2019.

 

• Patel, K.K., Karanjah, E., Ghazaryan, N., Loomba, S., Samra, G.K., Krishnam, M., Mukherjee J. Upregulation of nicotinic acetylcholinergic receptors in human lung adenocarcinomas. Journal of Nuclear Medicine, Vol. 60, Supplement 1, 1406, 2019. Presented at the 66th Annual Meeting of Society of Nuclear Medicine and Molecular Imaging, Anaheim, California, June 22-25, 2019.

 

• Ghazaryan, N., Patel, K.K., Samra, G.K., Mukherjee J. Nicotinic a4b2* receptors in anterior cingulate of postmortem human Alzheimer’s disease and Parkinson’s disease brain. Journal of Nuclear Medicine, Vol. 60, Supplement 1, 1305, 2019. Presented at the 66th Annual Meeting of Society of Nuclear Medicine and Molecular Imaging, Anaheim, California, June 22-25, 2019.

 

• Liang, C., Liu, H., Singh, K., Mukherjee, J., Lau, W.L. [89Zr]DFO-anti-Klotho mAb for PET imaging of kidneys. Journal of Nuclear Medicine, Vol. 60, Supplement 1, 410, 2019. Presented at the 66th Annual Meeting of Society of Nuclear Medicine and Molecular Imaging, Anaheim, California, June 22-25, 2019.

 

• Buchsbaum, M.S., Mitelman, S.A., Christian, B.T., Merrill, B.M., Buchsbaum, B.R., Mukherjee, J.,Lehrer, D.S. Multimodal FDG, fractional anisotropy, dopamine receptor, and MRI imaging in schizophrenia. Presented at the Human Brain Mapping Meeting, Rome, June 9-13, 2019).

 

• Singh, K., Govind, A.P., Samra, G.K., Green, W.N., Chen, C.T., Mukherjee J. Fluorescence imaging probes for nicotinic acetylcholine a4b2* receptors. Journal of Nuclear Medicine, Vol. 60, Supplement 1, 1175, 2019. Presented at the 66th Annual Meeting of Society   of Nuclear Medicine and Molecular Imaging, Anaheim, California, June 22-25, 2019.

 

• Samra, G.K., Dang K., Ho, H., Baranwal, A., Mukherjee J. Dual targeting agents for Ab plaque/P-glycoprotein and Ab plaque/nicotinic acetylcholine a4b2* receptors for Ab Plaque removal. (Presented at the 65th Annual Meeting of Society of Nuclear Medicine, Philadelphia, PA, June 23-26, 2018).

 

• Toth, M., Nag, S., Jia, Z., Haggkvist, J., Mukherjee, J., Varrone, A., Halldin, C. Injected mass is a limiting factor for small animal PET studies using high-affinity radioligands. Eur J. Nucl Med Mol Imag, 44(suppl 2): S364-S365, 2017 (Presented at the Annual Congress of the European Association of Nuclear Medicine, Vienna, Austria, October 21-25, 2017).

 

• Lao, P., Betthauser, T., Tudorascu ,D., Barnhart, T., Mukherjee, J., Christian B. First-in-humans study: Biodistribution, test-retest variability, and dosimetry of the a4b2* nicotinic acetylcholine receptor agonist, [¹⁸F]nifene. Nucl. Med., 58 (6)suppl: , 2017 (Presented at the 64th Annual Meeting of Society of Nuclear Medicine, Denver, CO, June 10-14, 2017).

 

• Liang, C., Samra, G.K., Mukherjee J. Nifrodansyl: A new fluorescence imaging probe for nicotinic acetylcholine a4b2* receptors. Nucl. Med., 58 (6)suppl: , 2017 (Presented at the 64th Annual Meeting of Society of Nuclear Medicine, Denver, CO, June 10-14, 2017).

 

• Vyas, N.S., Lehrer, D.S., Merrill, B., DeCastro A, Doninger, N.A., Christian, B.T., Mukherjee, J.,Buchsbaum, M.S.: D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophenia. Biological Psychiatry, 81(10):supplement, May 2017.

 

• Lao, P., Betthauser, T., Barnhart ,T., Mukherjee, J., Christian, B. Test-retest variability of the a4b2 nicotinic acetylcholine receptor agonist, [¹⁸F]nifene, in humans. Presented at the 13^th International Conference on Quantification of Brain Function with PET, Berlin, Germany, April 1-4, 2017.

 

• Schade, K.N., Baranwal A, Mukherjee J. Comparison of brown adipose tissue activation in type 1 and type 2 (obese) diabetic rodent models using 18F-FDG PET/CT. Nucl. Med., 57 (6)suppl: 1134, 2016 (Presented at the 63rd Annual Meeting of Society of Nuclear Medicine, San Diego, CA, June 11-15, 2016).

 

• Shah N.M., Mukherjee J. Development of imaging methods to assess glutamate function at the NMDA ion channel. Nucl. Med., 57 (6)suppl: 1038, 2016 (Presented at the 63rd Annual Meeting of Society of Nuclear Medicine, San Diego, CA, June 11-15, 2016).

 

• Patel, I.H., Liang, C., Mukherjee J. New precursor in improved 18F-nifene synthesis for imaging nicotinic receptors. Nucl. Med., 57 (6)suppl: 1086, 2016 (Presented at the 63rd Annual Meeting of Society of Nuclear Medicine, San Diego, CA, June 11-15, 2016).

 

• Liang, C., Patel, I.H., Mukherjee J. Affinity and selectivity of nifene for human nicotinic receptor subtypes. Nucl. Med., 57 (6)suppl: 1798, 2016 (Presented at the 63rd Annual Meeting of Society of Nuclear Medicine, San Diego, CA, June 11-15, 2016).

 

• Ho, H.M., Baranwal A, Mukherjee J. Evaluation of fluorinated TAZA analogs as potential ligands for Ab J. Nucl. Med., 57 (6)suppl: 1031, 2016 (Presented at the 63rd Annual Meeting of Society of Nuclear Medicine, San Diego, CA, June 11-15, 2016).

 

• Patel I, Kuruvilla S, Hillmer A, Lao P, Betthauser T, Pan M-L, Baranwal A, Christian B, Mukherjee J. ¹⁸F-Nifene: Efficacy as PET imaging agent of nicotinic a4b2 receptors from mice to humans. Nucl. Med., 56 (suppl): 490, 2015 (Presented at the 62nd Annual Meeting of Society of Nuclear Medicine, Baltimore, MD, June 6-10, 2015).

 

• Liang C, Kuruvilla S, Pan M-L, Hoang A, Ho H, Mukherjee J. Evaluation of nicotinic a4b2 receptor antagonists for potential imaging by PET and SPECT. Nucl. Med., 56 (suppl): 1093, 2015 (Presented at the 62nd Annual Meeting of Society of Nuclear Medicine, Baltimore, MD, June 6-10, 2015).

 

• Shah N, Mukherjee J. Glutamate-induced hyperactivity of NMDA ion channel in postmortem Alzheimer’s disease brains. Nucl. Med., 56 (suppl): 411, 2015 (Presented at the 62nd Annual Meeting of Society of Nuclear Medicine, Baltimore, MD, June 6-10, 2015).

 

• Schade K, Baranwal A, Liang C, Mirbolooki MR, Mukherjee J. Obese zucker rat exhibits decreased b3-adrenoceptor-induced ¹⁸F-FDG metabolic activity in brown adipose tissue. Nucl. Med., 56 (suppl): 1082, 2015 (Presented at the 62nd Annual Meeting of Society of Nuclear Medicine, Baltimore, MD, June 6-10, 2015).

 

• Baranwal A, Mukherjee J. ¹⁸F-rFDGSCH: A novel fluorine-18 PET imaging agent for dopamine D1 receptors. Nucl. Med., 56 (suppl): 1049, 2015 (Presented at the 62nd Annual Meeting of Society of Nuclear Medicine, Baltimore, MD, June 6-10, 2015).

 

• Lao P, Betthauser T, Hillmer A, Kuruvilla S, Higgins A, Barnhart T, Nickles R, Stone C, Mukherjee J, Christian B. ¹⁸F-Nifene a4b2 nAChR binding characteristics from a first-in-human PET study. Nucl. Med., 56 (suppl): 1616, 2015 (Presented at the 62nd Annual Meeting of Society of Nuclear Medicine, Baltimore, MD, June 6-10, 2015).

 

• Mukherjee J, Lao P, Betthauser T, Hillmer A, Pan ML, Patel I, Kuruvilla S, Higgins A, Barnhart T, Stone C, Christian B. ¹⁸F-Nifene: first-in-human PET studies for imaging nicotinic a4b2 receptors. Presented at the World Molecular Imaging Congress (WMIC), Abstract #SS162, Honolulu, Hawaii, September 5, 2015.

 

• Kuruvilla S, Mukherjee J. Suppression of acetylcholine breakdown by butyrylcholinesterase inhibitor in postmortem Alzheimer’s disease brain. Nucl. Med., 55 (suppl): 416, 2014 (Presented at the 61th Annual Meeting of Society of Nuclear Medicine, St. Louis, MO, June 7-11, 2014).

 

• Baranwal A, Mukherjee J. Reductive amination of ¹⁸F-fluorodeoxyglucose to 18F-rFDGlbiological amines. Nucl. Med., 55 (suppl): 157, 2014 (Presented at the 61th Annual Meeting of Society of Nuclear Medicine, St. Louis, MO, June 7-11, 2014).

 

• Bajwa A, Hillmer A, Wooten D, Saigal N, Christian B, Mukherjee J. ¹⁸F-Mefway: Efficacy as a PET imaging agent for serotonin 5HT1A receptors. Nucl. Med., 55 (suppl): 553, 2014 (Presented at the 61th Annual Meeting of Society of Nuclear Medicine, St. Louis, MO, June 7-11, 2014).

 

• Venugopal A, Mukherjee J. Alterations in serotonin and dopamine receptors in Alzheimer’s disease brain. Nucl. Med., 55 (suppl): 1853, 2014 (Presented at the 61th Annual Meeting of Society of Nuclear Medicine, St. Louis, MO, June 7-11, 2014).

 

• Hillmer A, Lao P, Betthauser T, Barnhart T, Rowley H, Hall L, Stone C, Mukherjee J, Christian B. ¹⁸F-Mefway PET imaging of serotonin 5-HT1A receptors in humans. Nucl. Med., 55 (suppl): in press, 2014 (Presented at the 61th Annual Meeting of Society of Nuclear Medicine, St. Louis, MO, June 7-11, 2014).

 

• Bajwa A, Hillmer A, Christian BT, Wooten D, Saigal N, Mukherjee J. PET imaging of serotonin 5HT1A receptors with 18F-Mefway: translation from animal models to human studies. Abstract # O-005 Presented at the 10th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, Egmond aan Zee, The Netherlands, May 21-24, 2014).

 

• Hillmer A, Wooten D, Farhoud M, Higgins AT, Lao PJ, Betthauser TJ, Barnhart TE, Mukherjee J, Christian BT. Acetylcholinesterase inhibitor induced reductions to ¹⁸F-nifene binding. Abstract # P-101 Presented at the 10th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, Egmond aan Zee, The Netherlands, May 21-24, 2014).

 

• Venugopal A, Mukherjee J. Serotonin and dopamine receptor changes in post-mortem Alzheimer’s disease brain. Abstract # P-107 Presented at the 10th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, Egmond aan Zee, The Netherlands, May 21-24, 2014).

 

• Kuruvilla S, Mukherjee J. Acetylcholine breakdown is greater in postmortem Alzheimer’s disease frontal cortex. Abstract # P-108 Presented at the 10th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, Egmond aan Zee, The Netherlands, May 21-24, 2014).

 

• Baranwal A, Mukherjee J. 18F-rFluorodeoxyglycosylamines (18F-rFDGly): Reductive amination of ¹⁸F-fluorodeoxyglucose using biological amines. Abstract # P-110 Presented at the 10th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, Egmond aan Zee, The Netherlands, May 21-24, 2014).

 

• Hillmer AT, Wooten DW, Lao PJ, Higgins AT, Betthauser TJ, Barnhart TE, Rowley HA, Hall LT, Stone CK, Mukherjee J, Christian BT. PET imaging of serotonin 5HT1A receptors with ¹⁸F-Mefway in humans. Abstract # O-019 Presented at the 10th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, Egmond aan Zee, The Netherlands, May 21-24, 2014).

 

• Bajwa A, Patel H, Pan ML, Liang C, Mukherjee J. Evaluation of serotonin 5HT1A receptors in postmortem Alzheimer’s disease brain. Nucl. Med., 54 (suppl):1791, 2013 (Presented at the 60^th Annual Meeting of Society of Nuclear Medicine, Vancouver, Canada, June 8-12, 2013).

 

• Baranwal A, Liang C, Pan ML, Mirbolooki MR, Constantinescu, C. Mukherjee J. ¹⁸F-Fluorodeoxyglycosylamine: Maillard reaction of ¹⁸F-FDG with biological amines. Nucl. Med., 54 (suppl):1071, 2013 (Presented at the 60^th Annual Meeting of Society of Nuclear Medicine, Vancouver, Canada, June 8-12, 2013).

 

• Mukherjee J, Pan ML, Mirbolooki MR, Constantinescu, C, Baranwal A, Liang C. Norepinephrine uptake imaging in rodent brain and brown adipose tissue. Nucl. Med., 54 (suppl):1119, 2013 (Presented at the 60^th Annual Meeting of Society of Nuclear Medicine, Vancouver, Canada, June 8-12, 2013).

 

• Patel H, Patel B, Pan ML, Liang C, Mukherjee M, Mukherjee J. Norepinephrine effects on Ab-amyloid plaques in post-mortem Alzheimer’s disease brain. Nucl. Med., 54 (suppl):1790, 2013 (Presented at the 60^th Annual Meeting of Society of Nuclear Medicine, Vancouver, Canada, June 8-12, 2013).

 

• Kuruvilla S, Hillmer A, Wooten D, Liang C, Barnhart T, Christian B, Mukherjee J. ¹⁸F-Niofene: A novel PET/SPECT imaging agent for nicotinic receptors. Nucl. Med., 54 (suppl):1111, 2013 (Presented at the 60^th Annual Meeting of Society of Nuclear Medicine, Vancouver, Canada, June 8-12, 2013).

 

• Kuruvilla S, Bajwa A, Patel H, Pan ML, Mukherjee J. Reduction of nicotinic a4b2 receptors in postmortem human Alzheimer’s disease brain. Nucl. Med., 54 (suppl):472, 2013 (Presented at the 60^th Annual Meeting of Society of Nuclear Medicine, Vancouver, Canada, June 8-12, 2013).

 

• Thio J, Liang C, Bajwa A, Wooten D, Hillmer A, Mukherjee J. Positional isomers of Mefway for imaging serotonin 5HT1a receptors. Nucl. Med., 54 (suppl):1104, 2013 (Presented at the 60^th Annual Meeting of Society of Nuclear Medicine, Vancouver, Canada, June 8-12, 2013).

 

• Mirbolooki MR, Constantinescu CC, Pan M, Mukherjee J. ¹⁸F-FDG PET imaging of brown adipose tissue to evaluate b3-adrenoreceptor efficacy in vivo. Nucl. Med., 54 (suppl):1216, 2013 (Presented at the 60^th Annual Meeting of Society of Nuclear Medicine, Vancouver, Canada, June 8-12, 2013).

 

• Wooten D, Hillmer A, Moirano J, Ahlers E, Slesarev M, Barnhart T, Mukherjee J, Schneider M,Christian B. Error analysis of group input function uncertainities in ¹⁸F-mefway PET. Nucl. Med., 54 (suppl):2043, 2013 (Presented at the 60^th Annual Meeting of Society of Nuclear Medicine, Vancouver, Canada, June 8-12, 2013).

 

• Hillmer AT, Wooten DW, Slesarev M, Ahlers E, Barnhart T, Schneider M, Mukherjee J, Christian BT. Evaluation of experimental protocols to accurately measure a4b2 nicotnic acetylcholine receptor density with ¹⁸F-nifene. Nucl. Med., 54 (suppl):203, 2013 (Presented at the 60^th Annual Meeting of Society of Nuclear Medicine, Vancouver, Canada, June 8-12, 2013).

 

• Hillmer AT, Wooten DW, Farhoud M, Barnhart T, Mukherjee J, Christian BT. Lobeline competes with ¹⁸F-nifene at the a4b2 nicotinic acetylcholine receptor and reduces plasma-to-tissue transport rates. Nucl. Med., 54 (suppl):1738, 2013 (Presented at the 60^th Annual Meeting of Society of Nuclear Medicine, Vancouver, Canada, June 8-12, 2013).

 

• Wooten DW, Hillmer AT, Lao T, Thio J, Bajwa AK, Liang C, Barnhart TE, Schneider ML, Mukherjee J, Christian BT. An in vivo comparison of 3- and 4- [¹⁸F]Mefway in the nonhuman primate using PET. Presented at the 6th Annual World Molecular Imaging Congress, Savannah, Georgia, September 18-21, 2013).

 

• Metherate R, Bieszczad K, Kant R, Constantinescu C, Kawai H, Weinberger N, Mukherjee J. Using PET imaging and autoradiography to link brain nicotinic acetylcholine receptors to cognitive function in rat. Abstract #483, Presented at the 35^th Annual Mid-Winter meeting of the Association for Research in Otolaryngology, San Diego, CA, February 25-29, 2012.

 

• Upadhyaya SK, Mahan K-E, Mirbolooki MR, Tjong I, Mukherjee J, Iadonato S.P., Sassoni-Corsi, P,Wang PH, Chandy GK. Anti-Obesity effect of ShK-186, a K+ channel blocker. Presented at the 56^th Annual Biophyscial Society Meeting, San Diego, CA, February 25-29, 2012.

 

• Hillmer A, Wooten D, Slesarev M, Ahlers E, Barnhart T, Mukherjee J, Schneider M, Chrisitan B. Quantitative analysis of 18F-nifene kinetics in the nonhuman primate. Nucl. Med., 53(suppl):94, 2012 (Presentation at the 59^th Annual Meeting of Society of Nuclear Medicine, Miami, Florida, June 9-13, 2012).

 

• Hillmer A, Wooten D, Engle J, Barnhart T, Nickles R, Murali D, Mukherjee J, Chrisitan B. Improvements to the radiosynthesis of 18F-nifene. Nucl. Med., 53(suppl):1462, 2012 (Presentation at the 59^th Annual Meeting of Society of Nuclear Medicine, Miami, Florida, June 9-13, 2012).

 

• Patel B, Pan ML, Liang C, Mirbolooki RM, Constantinescu C, Mukherjee J. 11C-Dalene, a new agent for beta amyloid senile plaques in the human brain. Nucl. Med., 53(suppl):1604, 2012 (Presentation at the 59^th Annual Meeting of Society of Nuclear Medicine, Miami, Florida, June 9-13, 2012).

 

• Thio J, Liang C, Pan ML, Mirbolooki RM, Constantinescu C, Mukherjee J. 3-18F-Mefway, an isomeric analog of mefway for imaging serotonin 5HT1a receptors. Nucl. Med., 53(suppl):1611, 2012 (Presentation at the 59^th Annual Meeting of Society of Nuclear Medicine, Miami, Florida, June 9-13, 2012).

 

• Liang C, Pan ML, Mirbolooki RM, Constantinescu C, Mukherjee J. Synthesis and analysis of 18F-4-fluoromethylcyclohexanoic acid, a metabolite of 18F-mefway. Nucl. Med., 53(suppl):1625, 2012 (Presentation at the 59^th Annual Meeting of Society of Nuclear Medicine, Miami, Florida, June 9-13, 2012).

 

• Bui V, Pan ML, Liang C, Mirbolooki RM, Constantinescu C, Mukherjee J. Schiff base PET imaging analogs for human Alzheimer’s disease (AD) senile plaque. Nucl. Med., 53(suppl):1626, 2012 (Presentation at the 59^th Annual Meeting of Society of Nuclear Medicine, Miami, Florida, June 9-13, 2012).

 

• Mukherjee M, Pan ML, Mirbolooki RM, Constantinescu C, Mukherjee J. 11C-TAZA, a new PET imaging agent for Ab-amyloid plaques in the human brain. Nucl. Med., 53(suppl):1631, 2012 (Presentation at the 59^th Annual Meeting of Society of Nuclear Medicine, Miami, Florida, June 9-13, 2012).

 

• Majji D, Pan ML, Mirbolooki RM, Constantinescu C, Mukherjee J. Rodent PET evaluation of fluorine-18 labeled dopamine D3 receptor agonist, 18F-7-OH-FHXPAT. Nucl. Med., 53(suppl):1634, 2012 (Presentation at the 59^th Annual Meeting of Society of Nuclear Medicine, Miami, Florida, June 9-13, 2012).

 

• Wooten D, Hillmer A, Moirano J, Ahlers E, Slesarev M, Barnhart T, Mukherjee J, Schneider, M, Christian B. An in vivo comparison of 5-HT1a receptor density, Bmax, and BPND using 18F-mefway. Nucl. Med., 53(suppl):213, 2012 (Presentation at the 59^th Annual Meeting of Society of Nuclear Medicine, Miami, Florida, June 9-13, 2012).

 

• Constantinescu C, Mirbolooki RM, Bhatt V, Pan ML, Borreli E, Mukherjee J. Probing the D3R system using D2R knockout mice imaging with selective D3 agonist 18F-FHXPAT and D2/D3 antagonist 18F-Fallypride. Nucl. Med., 53(suppl):358, 2012 (Presentation at the 59^th Annual Meeting of Society of Nuclear Medicine, Miami, Florida, June 9-13, 2012).

 

• Mirbolooki RM, Constantinescu C, Pan ML, Mukherjee J. Imaging dopamine receptors in brown adipose tissue using 18F-fallypride and 18F-FHXPAT. Nucl. Med., 53(suppl):407, 2012 (Presentation at the 59^th Annual Meeting of Society of Nuclear Medicine, Miami, Florida, June 9-13, 2012).

 

• Mirbolooki RM, Constantinescu C, Naqvi SA, Thorosian N, Pan ML, Mukherjee J. Enhancement of brown adipose tissue metabolism through adrenergic system activation quantifiable with 18F-FDG PET/CT in mice. Nucl. Med., 53(suppl):1776, 2012 (Presentation at the 59^th Annual Meeting of Society of Nuclear Medicine, Miami, Florida, June 9-13, 2012).

 

• Patel H, Raghani T, Mistry S, Pan ML, Mukherjee J. 18F-FBM binding to beta amyloid senile plaques and neurofibrillary tangles in the human brain. Nucl. Med., 53(suppl):1972, 2012 (Presentation at the 59^th Annual Meeting of Society of Nuclear Medicine, Miami, Florida, June 9-13, 2012).

 

• Garcia A, Constantinescu C, Pan ML, Mukherjee J. 18F-Fallypride PET/CT scanning in healthy and diabetic rodents. Nucl. Med., 53(suppl):2098, 2012 (Presentation at the 59^th Annual Meeting of Society of Nuclear Medicine, Miami, Florida, June 9-13, 2012).

 

• Constantinescu C, Corches A, Mirbolooki RM, Pan ML, Mukherjee J. Effect of acetylcholinesteraseinhibitor, donepzil, on in vivo binding of nicotinic a4b2 receptor agonist ¹⁸F-nifene in the rat brain. Nucl. Med., 53(suppl):1891, 2012 (Presentation at the 59^th Annual Meeting of Society of Nuclear Medicine, Miami, Florida, June 9-13, 2012).

 

• Pan M-L., Mukherjee M., Patel B., Patel H., Liang C., Vasilevko V., Constantinescu C, Mirbolooki MR, Mukherjee J. ¹¹C-TAZA and ¹¹C-Dalene: New PET imaging agents for human brain senile plaques also bind to norepinephrine transporter. Cereb. Blood Flow Metab., in press: 2012 (Presentation at the 9^th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, Baltimore, Maryland, August 9-11, 2012).

 

• Mirbolooki MR, Pan M-L., Patel B., Liang C., Patel H., Mukherjee M., Constantinescu C, Mukherjee J. Imaging norepinephrine transporter and glucose metabolism in rat brown adipose tissue. Cereb. Blood Flow Metab., 32: P089, 2012 (Presentation at the 9^th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, Baltimore, Maryland, August 9-11, 2012).

 

• Mukherjee J, Pan M-L., Liang C., Mukherjee M., Vasilevko V., Patel H., Constantinescu C, Mirbolooki MR. Norepinephrine binds to ¹¹C-PIB labeled b-amyloid plaques in post-mortem Alzheimer’s disease brain. Cereb. Blood Flow Metab., 32: P043, 2012 (Presentation at the 9^th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, Baltimore, Maryland, August 9-11, 2012).

 

• Constantinescu C, Pan M-L., Patel B., Mukherjee M., Patel H., Liang C., Mirbolooki MR, Mukherjee J. Preliminary evaluation of in vivo NET binding in the rat brain with ¹¹C-Dalene and ¹¹C-TAZA using PET imaging. Cereb. Blood Flow Metab., 32: P141, 2012 (Presentation at the 9^th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, Baltimore, Maryland, August 9-11, 2012).

 

• Constantinescu C, Borelli E, Pan M-L., Mirbolooki MR., Liang C., Mukherjee J. Evaluation of D3 versus D2 receptor binding in rats and D2R knockout mice using in vivo PET imaging with ¹⁸F-desmethoxyfallypride and ¹⁸F-fallypride. Cereb. Blood Flow Metab., 32: P047, 2012 (Presentation at the 9^th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, Baltimore, Maryland, August 9-11, 2012).

 

• Mukherjee J, Pan M-L., Himika Patel, Vasilevko V., Mukherjee M., Liang C., Constantinescu C, Mirbolooki MR. Norepinephrine competes with ¹¹C-PIB in post-mortem Alzheimer’s disease brain. (Presentation at the 42^nd Annual Meeting of the Society of Neuroscience, New Orleans, Louisiana, October 13-17, 2012).

 

• Tang W, Galitovskiy V, Sevrioukov E, Pan ML, Constantinescu C, Grando S, Mukherjee J. 18F-FAHA PET for imaging histone deacetylase in lung cancer. Nucl. Med., 52(suppl):411, 2011 (Presentation at the 58^th Annual Meeting of Society of Nuclear Medicine, San Antonio, Texas, June 4-8, 2011).

 

• Garcia A, Grewal S, Milne N, Mirbolooki MR, Constantinescu C, Pan ML, Wang P, Chandy KG, Mukherjee J. 18F-Fallypride PET/CT scanning in type 1 diabetic patients. Nucl. Med., 52(suppl):222, 2011 (Presentation at the 58^th Annual Meeting of Society of Nuclear Medicine, San Antonio, Texas, June 4-8, 2011).

 

• Pithia N, Gulati N, Pan ML, Sevrioukov E, Constantinescu C, Mukherjee J. 18F-Festron: A potential serotonin 5-HT3 receptor PET imaging agent. Nucl. Med., 52(suppl):227, 2011 (Presentation at the 58^th Annual Meeting of Society of Nuclear Medicine, San Antonio, Texas, June 4-8, 2011).

 

• Mirbolooki MR, Sevrioukov E, Garcia A, Constantinescu C, Mukherjee J. Imaging brown adipose tissue activation using b3-adrenoreceptor agonist. J. Nucl. Med., 52(suppl):516, 2011 (Presentation at the 58^th Annual Meeting of Society of Nuclear Medicine, San Antonio, Texas, June 4-8, 2011).

 

• Wooten D, Moirano J, Hillmer A, Barnhart T, Murali D, Mukherjee J, Schneider M, Christian B. Measurement of 5-HT1A receptor density and in vivo KD of [F-18]Mefway in the nonhuman primate. Nucl. Med., 52(suppl):1180, 2011 (Presentation at the 58^th Annual Meeting of Society of Nuclear Medicine, San Antonio, Texas, June 4-8, 2011).

 

• Hillmer A, Wooten D, Moirano J, Engle J, Barnhart T, Nickles R, Murali D, Schneider M, Mukherjee J, Christian B. Nicotinic acetylcholine receptor binding of [F-18]Nifene in the rhesus monkey. Nucl. Med., 52(suppl):1183, 2011 (Presentation at the 58^th Annual Meeting of Society of Nuclear Medicine, San Antonio, Texas, June 4-8, 2011).

 

• Khararjian A, Constantinescu C, Coleman R, Pan ML, Mukherjee J. Comparative PET imaging of D2/D3 receptors in the rodent spinal cord with [18F]fallypride and [11C]fallypride. Nucl. Med., 52(suppl):1193, 2011 (Presentation at the 58^th Annual Meeting of Society of Nuclear Medicine, San Antonio, Texas, June 4-8, 2011).

 

• Constantinescu C, Garcia A, Sevrioukov E, Pan ML, Mukherjee J. Evaluation of [18F]Mefway biodistribution based on whole-body MicroPET imaging in mice. Nucl. Med., 52(suppl):1462, 2011 (Presentation at the 58^th Annual Meeting of Society of Nuclear Medicine, San Antonio, Texas, June 4-8, 2011).

 

• Constantinescu C, Garcia A, Sevrioukov E, Pan ML, Mukherjee J. Evaluation of [18F]Nifene biodistribution based on whole-body MicroPET imaging in mice. Nucl. Med., 52(suppl):1468, 2011 (Presentation at the 58^th Annual Meeting of Society of Nuclear Medicine, San Antonio, Texas, June 4-8, 2011).

 

• Cheong F, Sevrioukov E, Mukherjee J. Development of CT contrast agent for rat pancreas. Nucl. Med., 52(suppl):1544, 2011 (Presentation at the 58^th Annual Meeting of Society of Nuclear Medicine, San Antonio, Texas, June 4-8, 2011).

 

• Fong V, Faheem S, Sevrioukov E, Constantinescu C, Pan ML, Mukherjee J. 18F-Mefway MicroPET imaging in rat brains. Nucl. Med., 52(suppl):1571, 2011 (Presentation at the 58^th Annual Meeting of Society of Nuclear Medicine, San Antonio, Texas, June 4-8, 2011).

 

• Mistry S, Pan ML, Sevrioukov E, Constantinescu C, Mukherjee J. Evaluation of 18F-FBM in triple transgenic mice. Nucl. Med., 52(suppl):1572, 2011 (Presentation at the 58^th Annual Meeting of Society of Nuclear Medicine, San Antonio, Texas, June 4-8, 2011).

 

• Galitovskiy V, Sevrioukov E, Corches A, Pan ML, Constantinescu C, Grando S, Mukherjee J. 18F-Nifene PET for early diagnosis of lung cancer. Nucl. Med., 52(suppl):1578, 2011 (Presentation at the 58^th Annual Meeting of Society of Nuclear Medicine, San Antonio, Texas, June 4-8, 2011).

 

• Patel R, Ali S, Coleman R, Constantinescu C, Pan M-L, Head E, Mukherjee J. Imaging Alzheimer’s disease mouse models using 18F-FDG PET. Presented at the World Molecular Imaging Congress, San Diego, CA Sept 5-9, 2011.

 

• Mirbolooki MR, Sun A, Constantinescu C, Garcia A, Pan M-L, Wang P, Mukherjee J. Tomoxetine increases metabolism in brown adipose tissue measurable by 18F-FDG PET: A potential antiobesity approach. Presented at the World Molecular Imaging Congress, San Diego, CA Sept 5-9, 2011.

 

• Wooten DW, Hillmer AT, Murali D, Barnhart TE, Schneider ML, Mukherjee J, Christian, BT.A comparison of cis- and trans- 18F-mefway in the nonhuman primate using PET. Presented at the 19^th International Symposium on Radiopharmaceutical Sciences, Amsterdam, August 28-September 2, 2011 (pp.S258).

 

• Hillmer AT, Wooten DW, Moirano JD, Slesarev MS, Engle JW, Barnhart TE, Nickles RJ, Schneider ML, Mukherjee J, Christian BT. PET studies with 18F-Nifene for imaging a4b2 nicotinic acetylcholine receptors: Age dependent changes in the rhesus monkey. Abstract #744.04, Presented at the Soceity of Neuroscience, Washington DC, Nov. 12-16, 2011.

 

• Sevrioukov, E., Garcia, A., Constantinescu, C., Mukherjee, J; Inveon MicroCT imaging of the rat spleen. Nucl. Med., 51:1011, 2010 (Presentation at the 57^th Annual Meeting of Society of Nuclear Medicine, Salt Lake City, Utah, June 5-8, 2010).

 

• Jerjian, T., Constantinescu, C., Sevrioukov, E., Mukherjee, J.; Evaluation of dopamine D3 receptor binding of 18F-fallypride. Nucl. Med., 51:1762, 2010 (Presentation at the 57^th Annual Meeting of Society of Nuclear Medicine, Salt Lake City, Utah, June 5-8, 2010).

 

• Garcia, A., Sevrioukov, E., Constantinescu, C., Pan, M.L., Chandy, K.G., Mukherjee, J.; Dual probe microPET imaging of rodent pancreas. Nucl. Med., 51:88, 2010 (Presentation at the 57^th Annual Meeting of Society of Nuclear Medicine, Salt Lake City, Utah, June 5-8, 2010).

 

• Wooten, D., Moirano, J., Murali, D., Hillmer, A., DeJesus, O., Barnhart, T., Nickles, J., Mukherjee, J., Schneider, M., Christian, B.; The in vivo kinetics of three 5-HT1a PET antagonists in the rhesus monkey. Nucl. Med., 51:163, 2010 (Presentation at the 57^th Annual Meeting of Society of Nuclear Medicine, Salt Lake City, Utah, June 5-8, 2010).

 

• Vu, K., Sevrioukov, E., Constantinescu, C., Pan, M.L., Pichika, R., Mukherjee, J.; 18F-Nifrolene MicroPET studies of nicotinic a4b2 receptors. Nucl. Med., 51:219, 2010 (Presentation at the 57^th Annual Meeting of Society of Nuclear Medicine, Salt Lake City, Utah, June 5-8, 2010).

 

• Wooten, D., Hillmer, A., Moirano, J., Tudorascu, D., Murali, D., Barnhart, D., Kalin, N., Davidson, R., Mukherjee, J., Schneider, M., Christian, B.; 5-HT1A binding of 18F-Mefway in the rhesus monkey. Neuroimage, 52: S129, 2010 (Presented at the 8^th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, July 22-26, 2010, Glasgow, Scotland.

 

• Kant, R., Parekh, P., Pandey, S.K., Pan, M-L, Coleman, R., Constantinescu, C., Mukherjee, J. Evaluation of α4β2 receptor occupancy by Nicotine using ¹⁸F-Nifene. Journal Nuclear Medicine, 50(suppl2):607, 2009 (Presented at the 56^th Annual Society of Nuclear Medicine Meeting, Toronto, June 13-17, 2009).

 

• Dinh, T., Faheem, S., Rana, N., Saigal, N., Pandey, S., Head, E. and Mukherjee, J.: Evaluation of serotonin receptors using 18F-trans-Mefway in aging canine model. Journal of Nuclear Medicine, 50 (suppl 2):224P, 2009 (Presentation at the 56^th Annual Meeting of Society of Nuclear Medicine, Toronto, Canada, June 12-17, 2009).

 

• Gulati, N., Pandey, S., Kant, R., Coleman, R., Pan, M., Constantinescu, C. and Mukherjee, J.: 18F-Norfallypride: A new PET radiotracer for imaging dopamine D3 receptors. Nucl. Med., 50:162P, 2009 (Oral Presentation at the 56^th Annual Meeting of Society of Nuclear Medicine, Toronto, Canada, June 13-17, 2009).

 

• Constantinescu, C., Kasabwala, K., Pandey, S., Pan, M.L., Coleman, R., Kant, R., Mukherjee, J.; Comparative rodent microPET study of 18F-fallypride and 18F-desmethoxyfallypride. Nucl. Med., 50:1207, 2009 (Presentation at the 56^th Annual Meeting of Society of Nuclear Medicine, Toronto, Canada, June 13-17, 2009).

 

• Pandey, S., Constantinescu, C., Coleman, R., Kant, R., Milne, N., Mukherjee, J.; 124I-Epidepride: A new PET tracer for extended imaging of dopamine receptors. Nucl. Med., 50:204, 2009 ( Presentation at the 56^th Annual Meeting of Society of Nuclear Medicine, Toronto, Canada, June 13-17, 2009).

 

• Garcia, A., Milne, N., Mirbolooki, M., Pan, M.L., Pandey, S., Constantinescu, C., Lakey, J., Wang, P., Mukherjee, J., Chandy, K.G.; 18F-Fallypride PET to monitor pancreatic beta cell loss in diabetes mellitus. Nucl. Med., 50:1947, 2009 (Presentation at the 56^th Annual Meeting of Society of Nuclear Medicine, Toronto, Canada, June 13-17, 2009).

 

• Pandey, S., Shah, A., Panchal, S., Easwaramoorthy, B., Constantinescu, C, Coleman, R. and Mukherjee, J.: Multimodality imaging probe for monitoring cell transplantation and migration. Journal of Labeled Compounds and Radiopharmaceuticals, 52(S1):S56, 2009 (Presentation at the 18^th International Symposium in Radiopharmaceutical Sciences, Edmonton, Canada, July 12-17, 2009).

 

• Christian, B., Vandehey, N., Moirano, J., Murali, D., Wooten, D., DeJesus, O., Barnhart, T., Nickles, J., Mukherjee, J., Schneider, M.; An in vivo comparison of two 5-HT1A PET ligands in the nonhuman primate. Nucl. Med., 50:488, 2009 (Presentation at the 56^th Annual Meeting of Society of Nuclear Medicine, Toronto, Canada, June 13-17, 2009).

 

• Vandehey, N., Moirano, J., Murali, D., Converse, A., Engle, J., Nickles, J., Holden, J., Mukherjee, J., Schneider, M., Christian, B.; Considerations in choosing a tracer for measuring extrastriatal dopamine D2/D3 binding. Nucl. Med., 50:604, 2009 (Presentation at the 56^th Annual Meeting of Society of Nuclear Medicine, Toronto, Canada, June 13-17, 2009).

 

• Gulati, N., Pandey, S., Kant, R., Constantinescu, C, Coleman, R., Pan, M. and Mukherjee, J.: Comparison of dopamine receptor binding of fallypride and norfallypride. Journal of Labeled Compounds and Radiopharmaceuticals, 52(S1):S75, 2009 (Presentation at the 18^th International Symposium in Radiopharmaceutical Sciences, Edmonton, Canada, July 12-17, 2009).

 

• Pandey, S., Shah, A., Panchal, S., Easwaramoorthy, B., Constantinescu, C., Coleman, R., Kant, R., Mukherjee, J.; Multimodality imaging probe for monitoring cell transplantation and migration. Journal of Labeled Compounds and Radiopharmaceuticals, 52(S1):S56, 2009 (Presentation at the 18^th International Symposium in Radiopharmaceutical Sciences, Edmonton, Canada, July 12-17, 2009).

 

• Pandey, S., Pan, S., Kant, R., Coleman, R., Constantinescu, C., Pan, M.L., Mukherjee, J.; 123I-Niodene: A new SPECT tracer for imaging nicotinic receptors. Journal of Labeled Compounds and Radiopharmaceuticals, 52(S1):P119, 2009 (Presentation at the 18^th International Symposium in Radiopharmaceutical Sciences, Edmonton, Canada, July 12-17, 2009).

 

• Tran, M.T., Shah, S.R., Kim, K., Trinidad, P., Pandey,S., Karmur, A., Patel, R., Kant, R., Mukherjee, J.; Evaluation of dopamine receptor agonists, 18F-5-OH-FPPAT, 18F-5-OH-FHXPAT and 18F-7-OH-FHXPAT. Journal of Labeled Compounds and Radiopharmaceuticals, 52(S1):P245, 2009 (Presentation at the 18^th International Symposium in Radiopharmaceutical Sciences, Edmonton, Canada, July 12-17, 2009).

 

• Murali, D., Vandehey, N.T., Mukherjee, J., Davidson, R.J., Nickles, R.J., Christian, B.T..; An efficient synthesis of 11C-fallypride, a dopamine D2/D3 tracer. Journal of Labeled Compounds and Radiopharmaceuticals, 52(S1):P328, 2009 (Presentation at the 18^th International Symposium in Radiopharmaceutical Sciences, Edmonton, Canada, July 12-17, 2009).

 

• Mukherjee, J., Kasabwala, K., Kant, R., Pandey, S., Constantinescu, C., Coleman, R., M.-L. Pan.,Parekh, P. Acute nicotine effects on the distribution of nicotine a4b2 and dopamine D2/D3 receptor PET radiotracers. Journal Cerebral Blood Flow & Metabolism, 29: S12-S13, 2009 (Presented at the IXth International Conference on Quantification of Brain Function with PET held in Chicago, USA, between June 29^th and July 3^rd 2009).

 

• Dinh, T., Faheem, S., Rana, N., Saigal, N., Pandey, S., Pan, M.L., Head, E. and Mukherjee, J.: Imaging serotonin receptors using 18F-Mefway in aging. Journal of Cerebral Blood Flow and Metabolism, 29: S357, 2009 (Presentation at the IX^th International Conference on Quantification of Brain Function with PET, Chicago, IL, June 29- July 3, 2009).

 

• Mirbolooki, M.R., Alexander, M., Kant, R., Constantinescu, C., Pan, M.L., Pandey, S., Coleman, R., Milne, N., Hoyt, D.B., Mukherjee, J., Lakey JRT.; Noninvasive imaging to monitor pancreatic islet function. Xenotransplantation, 16:417, 2009.

 

• Mirbolooki, M.R., Garcia, A., Constantinescu, C., Kant, R., Pan, M.L., Pandey, S., Coleman, R., Milne, N., Grewal, S., Wang, P., Hoyt, D.B., Chandy, G.K., Mukherjee, J., Lakey JRT.; 18F-Fallypride PET imaging to monitor transplanted islets. Xenotransplantation, 16:343, 2009.

 

• Patel, N.V., Easwaramoorthy, B., Sarsoza, F., Pichika, R., Head, E. and Mukherjee, J. Evaluation of 18F-nifrolene binding to transgenic mice model of Alzheimer’s disease. Annual Meeting, Society of Nuclear Medicine, June 14-18, 2008; New Orleans, Louisiana. Nucl. Med., 49:212P, 2008.

 

• Constantinescu, C.C. and Mukherjee, J. Performance evaluation of an Inveon PET preclinical scanner. Annual Meeting, Society of Nuclear Medicine, June 14-18, 2008; New Orleans, Louisiana. Nucl. Med., 49:404P, 2008.

 

• Patel, P., Sarsoza, F., Easwawramoorthy, B., Tsu, W., Head, E. and Mukherjee, J. ¹⁸F-Fluoropropyl curcumin: Improved radiosynthesis and binding to β-amyloid plaques in a transgenic mouse model of Alzheimer’s disease. Annual Meeting, Society of Nuclear Medicine, June 14-18, 2008; New Orleans, Louisiana. Nucl. Med., 49:287P, 2008.

 

• Easwaramoorthy, B., Pichika, R., Constantinescu, C., Saigal, N., Coleman, R. and Mukherjee, J. Measurement of brain and plasma metabolites of ¹⁸F-Nifene. Annual Meeting, Society of Nuclear Medicine, June 14-18, 2008; New Orleans, Louisiana. Nucl. Med., 49:142P, 2008.

 

• Patel, P.C., Sarsoza, F., Vasilevko, V., Pan, M.-L., Tsu, W., Constantinescu, C., Coleman, R., Head, E. and Mukherjee, J. ¹⁸F-Fluoropropyl curcumin binding to b-amyloid plaques in transgenic mouse model of Alzheimer’s disease. Neuroreceptor Mapping 2008, Pittsburgh, PA, July 17-19 (Neuroimage, 41:T115, 2008).

 

• Wang, C.S., Head, E., Tsu, W., Doshi, A., Vasilevko, V., Coleman, R., Constantinescu, C., Saigal, N., Pan, M.-L. and Mukherjee, J. Evaluation of ¹⁸F-FBM for imaging b-amyloid plaques and neurofibrillary tangles. Neuroreceptor Mapping 2008, Pittsburgh, PA, July 17-19 (Neuroimage, 41: T120, 2008).

 

• Constantinescu, C., Coleman, R., Pan, M.-L. and Mukherjee, J. Dynamic imaging of brain D2/3 receptors with ¹⁸F-fallypride in rodents using Inveon microPET. Neuroreceptor Mapping 2008, Pittsburgh, PA, July 17-19 (Neuroimage, 41: T126, 2008).

 

• Saigal, N., Faheem, S., Coleman, R., Constantinescu, C. and Mukherjee, J. Rodent study of ¹⁸F- mefway using microPET. Neuroreceptor Mapping 2008, Pittsburgh, PA, July 17-19 (Neuroimage, 41, T165, 2008).

 

• Easwaramoorthy, B., Coleman, R., Constantinescu, C., Pan, M.-L. and Mukherjee, J. ¹⁸F-Nifene for quantification of a4b2 nicotinic receptors. Neuroreceptor Mapping 2008, Pittsburgh, PA, July 17-19 (Neuroimage, 41: T181, 2008).

 

• Coleman, R., Constantinescu, C. and Mukherjee, J. Comparing 18F-FDG uptake in rodents using Inveon microPET: In vivo PET, ex vivo PET and autoradiographic imaging techniques. Neuroreceptor Mapping 2008, Pittsburgh, PA, July 17-19 (Neuroimage, 41: T179, 2008).

 

• Vandehey, NT., Moirano, J., Murali, D., Vogt, K., Converse, A., Nickles, RJ., Mukherjee, J., Larson, J., Schneider, M., Davidson, R. and Christian, B. A comparison of PET tracers for measuring extrastriatal dopamine D2/D3 binding. Soc. Neuroscience, 521.14, 2008.

 

• Patel, P.C., Collins, D., Nistor, M., Easwaramoorthy, B., Head, E. and Mukherjee, J.: 18F-Fluoropropylcurcumin: A potential PET tracer for imaging inflammation and Ab-plaques. Nucl. Med., 48:22P, 2007 (Presented at the 54^th Annual Meeting of Society of Nuclear Medicine, Washington, D.C., June 3-6, 2007) (Patel, P. Received Travel Award in Young Investigator Radiopharmaceutical Symposium).

 

• Kaghazwala, R.S., Chen, I., Wang, C., Easwaramoorthy, B., Nistor, M., Head, E., and Mukherjee, J.: Autoradiographic studies of 18F-FDDNP and 18F-FBM in transgenic mouse models. Nucl. Med., 48:115P, 2007 (Presented at the 54^th Annual Meeting of Society of Nuclear Medicine, Washington, D.C., June 3-6, 2007).

 

• Saigal, N., Easwaramoorthy, B., Nistor, M., Do, D., Head, E. and Mukherjee, J.: 18F-Mefway binding to serotonin 5HT1A receptors is reduced in transgenic mouse models of Alzheimer’s disease. Nucl. Med., 48:116P, 2007 (Presented at the 54^th Annual Meeting of Society of Nuclear Medicine, Washington ,D.C., June 3-6, 2007).

 

• Mukherjee, J., Patel, P.C., Le, J.M., Easwaramoorthy, B., Patel, N., Nistor, M., Pichika, R., and Head, E.: Nicotinic a4b2 receptors in transgenic mice models of Alzheimer’s disease. Nucl. Med., 48:116P, 2007 (Presented at the 54^th Annual Meeting of Society of Nuclear Medicine, Washington, D.C., June 3-6, 2007).

 

• Tam, P., Kaghazwala, R., Easwaramoorthy, B., Nistor, M., Head, E. and Mukherjee, J.: Reduction of dopamine D2/D3 receptors in transgenic mouse models of Alzheimer’s disease. Nucl. Med., 48:116P, 2007 (Presented at the 54^th Annual Meeting of Society of Nuclear Medicine, Washington, D.C., June 3-6, 2007).

 

• Nguyen, V., Pichika, R., Easwaramoorthy, B., Narayanan, T.K., Shi, B., Collins, D. and Mukherjee, J.: Synthesis and evaluation of novel norepinephrine transporter PET imaging agent (R)-18F-MFP3. Nucl. Med., 48:132P, 2007 (Presented at the 54^th Annual Meeting of Society of Nuclear Medicine, Washington, D.C., June 3-6, 2007).

 

• Easwaramoorthy, B., Pichika, R., Collins, D., Narayanan, T.K., Shi, B., Christian, B.T. and Mukherjee, J.: ¹⁸F-Nifene and ¹⁸F-Nifrolene: Novel nicotinic a4b2 receptor PET radiotracers. Presented at the Joint Molecular Imaging Conference, Sept. 8-11, 2007, Providence, Rhode Island.

 

• Lehrer, D.S., Short, H.M., Newmark, R.E., Christian, B.T., Murray, A., Shi, B., Narayanan, T.K., Kemether, E., Chu, K.W., Byne, W., Mukherjee, J., Mantil, J. and Buchsbaum, M.: Correlations between thalamic ¹⁸F-fallypride binding potential and thalamic and prefrontal 18F-FDG glucose uptake in a group of never medicated schizophrenics. Psychiatry, 59:1S-264S, 2006.

 

• Pichika, R., Easwaramoorthy, B., Collins, D., Potkin, S.G. and Mukherjee, J. ¹⁸F-Nifrolene: A New PET Imaging Agent for a4b2 nAChR Nicotinic Receptors. Nucl. Med., 47:27P, 2006. Presented at the 53^rd Annual Meeting of Society of Nuclear Medicine, San Diego, California, June 6-11, 2006.

 

• Easwaramoorthy, B., Pichika, R., Collins, D., Potkin, S.G. and Mukherjee, J. Effect of Acetylcholinesterase Inhibitors on a4b2 nAChR ligand, ¹⁸F-Nifene: A Measure of Acetylcholine Competition. Nucl. Med., 47:285P, 2006. Presented at the 53^rd Annual Meeting of Society of Nuclear Medicine, San Diego, California, June 6-11, 2006.

 

• Saigal, N., Easwaramoorthy, B., Pichika, R., Collins, D. and Mukherjee, J. Serotonin competition with the new 5-HT_1A receptor PET radiotracer: ¹⁸F-Mefway. Nucl. Med., 47:281P, 2006. Presented at the 53^rd Annual Meeting of Society of Nuclear Medicine, San Diego, California, June 6-11, 2006.

 

• Mukherjee, J., Easwaramoorthy, B., Chen, I., Collins, D., Pichika, R., Wang, C.S., Nguyen, V.L. and Head, E. Autoradiographic Studies of Tg2576 Mice with ¹⁸F-Nifene and ¹⁸F-FDDNP. Nucl. Med., 47:134P, 2006. Presented at the 53^rd Annual Meeting of Society of Nuclear Medicine, San Diego, California, June 6-11, 2006.

 

• Wang, C.S., Easwaramoorthy, B., Pichika, R., Collins, D., Head E. and Mukherjee, J. ¹⁸F-FBM: A New PET Radiotracer for Imaging β-Amyloid Plaques and Neurofibrillary Tangles. Nucl. Med., 47:217P, 2006. Presented at the 53^rd Annual Meeting of Society of Nuclear Medicine, San Diego, California, June 6-11, 2006.

 

• Trinidad, P.S., Kim, K., Pichika, R., Easwaramoorthy, B., Collins, D. and Mukherjee, J. Synthesis and Evaluation of the Dopamine D2 and D3 Receptor Agonists,(R,S)-¹⁸F-5-OH-FPPAT and (R,S)-¹⁸F-7-OH-FHXPAT. Presented at the 53^rd Annual Meeting of Society of Nuclear Medicine, San Diego, California, June 6-11, 2006.

 

• Nguyen, V., Pichika, R., Easwaramoorthy, B., Collins, D. and Mukherjee, J. F-18 labeled analogs of nisoxetine as PET imaging agents for norepinephrine transporters. Nucl. Med., 47:497P, 2006. Presented at the 53^rd Annual Meeting of Society of Nuclear Medicine, San Diego, California, June 6-11, 2006.

 

• Airaksinen, A.J., Finnema, S., Nag, S., Mukherjee, J., Farde, L. and Halldin, C. ¹¹C-Cyclopropyl-FLB-457: PET examination of a more D2 selective high affinity radioligand for extrastraital receptors. Presented at the Annual Congress of the European Association of Nuclear Medicine, Athens, Greece, September 30-October 4, 2006.

 

• Barnhart, T.E., Converse, A.K., Oakes, T.R., Nye, J.A., Dick, D.W., Murali, D., Ferrarelli, F., Massimini, M.,Tononi, G., Schneider, M.L., Larsen, J.A., Mukherjee, J., Stone, C.K., DeJesus, O.T., Nickles, R.J. and Roberts, A.D.: Methodological development of dynamic dopamine release using ¹⁸F-desmethoxyfallypride. Presented at the “VII^th International Conference on Quantification of Brain Function with PET”, Amsterdam, The Netherlands, June 7-11, 2005.

 

• Pichika, R., Collins, D., Christian, B.T., Shi, B., Narayanan, T.K., Leslie, F.M., Potkin, S.G. and Mukherjee, J.: Development of novel PET imaging agents for a4b2 receptors. ( Nucl. Med., 46: 137P, 2005). Presented at The Society of Nuclear Medicine 52^nd Annual Meeting, Toronto, Canada, June 18-22, 2005 (Awarded Certificate of Excellence by Indo-American Society of Nuclear Medicine).

 

• Saigal, N., Collins, D., Pichika, R., Wu, J., Potkin, S.G. and Mukherjee, J.: ¹⁸F-Mefway: A new radiotracer for serotonin 5HT_1A (J. Nucl. Med., 46: 27P, 2005). Presented at The Society of Nuclear Medicine 52^nd Annual Meeting, Toronto, Canada, June 18-22, 2005 (Awarded 1^st place in Young Investigator Radiopharmaceutical Symposium).

 

• Christian, B.T., Shi, B., Narayanan, T.K. and Mukherjee, J.: Comparison of novel carbon-11 labeled fallypride analogs for dopamine D2/D3 receptor PET imaging. ( Nucl. Med., 46: 346P, 2005). Presented at The Society of Nuclear Medicine 52^nd Annual Meeting, Toronto, Canada, June 18-22, 2005.

 

• Mukherjee, J., Keator, D., Collins, D., Jackson, H., Vivatpattanakul, B., Pichika, R., Christian, B., Fallon, J., Wu, J., Milne, N. and Potkin, S.G.: High resolution HRRT-¹⁸F-fallypride-PET of the human brain. ( Nucl. Med., 46: 287P, 2005). Presented at The Society of Nuclear Medicine 52^nd Annual Meeting, Toronto, Canada, June 18-22, 2005.

 

• Mukherjee, J., Collins, D., Pichika, R. and Saigal, N.: Effects of amyloid A42 on ¹⁸F-nifrolidine binding toa4b2 nicotinic receptors. ( Nucl. Med., 46: 289P, 2005) Presented at The Society of Nuclear Medicine 52^nd Annual Meeting, Toronto, Canada, June 18-22, 2005.

 

• Mukherjee, J., Collins, D., Pichika, R., Jackson, H. and Milne, N.: Automated radiosynthesis of ¹⁸F-fluorinated cholines. ( Nucl. Med., 46: 370P, 2005). Presented at The Society of Nuclear Medicine 52^nd Annual Meeting, Toronto, Canada, June 18-22, 2005.

 

• Pichika, R., Collins, D., Christian, B.T., Shi, B., Narayanan, T.K. and Mukherjee, J.: PET imaging agents for thalamic and extrathalamic 42 nicotinic receptors. Label.Compd. Radiopharm., 48:S9, 2005. Presented at The16th International Symposium on Radiopharmaceutical Chemistry, Iowa City, Iowa, June 24-28, 2005.

 

• Saigal, N., Collins, D., Pichika, R. and Mukherjee, J.: Towards a metabolically stable fluorine-18 PET radiotracer for serotonin 5HT1a receptors. Label. Compd. Radiopharm., 48:S85, 2005. Presented at 16th International Symposium on Radiopharmaceutical Chemistry, Iowa City, Iowa, June 24-28, 2005.

 

• Shi, B., Narayanan, T.K., Christian, B.T. and Mukherjee, J.: Radiosynthesis of 11C-methoxy-3-methoxy-5-(2’-propenyl)-N-[[(2S)-1-(2-propenyl)-2-pyrrolidinyl]methyl]benzamide as a new radiotracer for dopamine D2/D3 receptors. Label. Compd. Radiopharm., 48:S174, 2005). Presented at The 16th International Symposium on Radiopharmaceutical Chemistry, Iowa City, Iowa, June 24-28, 2005.

 

• Potkin, S.G., Mukherjee, J., Gharabawi, G. and Collins, D.: Dopamine and Serotonin receptor occupancy of long acting injectable risperidone in patients with schizophrenia. Neuropsychopharmacology, 30: S269-S270, 2005.

 

• Buchsbaum, M.S., Christian, B.T., Lehrer, D.S., Shi, B., Narayanan, T.K., Mukherjee, J.and Mantil, J.: ¹⁸F-Fallypride binding in never-medicated patients with schizophrenia. Presented at the American Psychiatric Association, APA 157^th Annual Meeting, New York, May 1-6, 2004.

 

• Buchsbaum, M.S., Christian, B.T., Lehrer, D.S., Shi, B., Narayanan, T.K., Mukherjee, J. and Mantil, J.: ¹⁸F-Fallypride binding in never-medicated patients with schizophrenia. Presented at the Society of Biological Psychiatry, 59^th Annual Meeting, New York, April 29^th-May 1^st, 2004.

 

• Christian, B.T., Buchsbaum, M.S., Lehrer, D.S., Narayanan, T.K., Shi, B., Mantil, J., Oakes, T.R. and Mukherjee, J.: D2/D3 dopamine receptor binding in medication naïve schizophrenics. Presented at “Human Brain Mapping 10^th Annual Meeting”, Budapest, Hungary, June 13-17, 2004.

 

• Xue, B., Collins, D., Flores, L., Barnhart, T., Converse, A., Murali, D., DeJesus, O., Nickles, J. and Mukherjee, J.: ¹⁸F-Fallypride binding in the rat spinal cord. ( Nucl. Med., 45: 258P, 2004). Presented at The Society of Nuclear Medicine 51^st Annual Meeting, Philadelphia, June 19-23, 2004.

 

• Christian, B.T., Buchsbaum, M.S., Lehrer, D.S., Shi, B., Narayanan, T.K., Mantil, J. and Mukherjee, J.: D2/D3 dopamine receptor binding in medication-naïve schizophrenics using ¹⁸F-fallypride PET. ( Nucl. Med., 45: 285P, 2004). Presented at The Society of Nuclear Medicine 51^st Annual Meeting, Philadelphia, June 19-23, 2004.

 

• Barnhart, T.E., Roberts, A.D., DeJesus, O.T., Flores, L.G., Murali, D., Oakes, T.R., Converse, A.K., Dick, D.W., Bartlett, R.M., Mukherjee, J., Nickles, R.J., Larson, J., Moore, C.F. and Schneider, M.L..: Paired ¹⁸F-FAL and ¹⁸F-FMT PET studies in timing of moderate alcohol exposure in rhesus monkeys during pregnancy. ( Nucl. Med., 45: 13P, 2004). Presented at The Society of Nuclear Medicine 51^st Annual Meeting, Philadelphia, June 19-23, 2004.

 

• Lindsey, K.P., Mukherjee, J., Gatley, S.J., Logan, J. and Fowler, J.S.: Effects of intravenous fluoxetine on ¹¹C-deprenyl binding in the baboon brain. ( Nucl. Med., 45: 257P, 2004). Presented at The Society of Nuclear Medicine 51^st Annual Meeting, Philadelphia, June 19-23, 2004.

 

• Buchsbaum, M.S., Christian, B.T., Lehrer, D.S., Mukherjee, J., Shi, B. and Mantil, J.: D2/D3 dopamine receptor binding in the thalamus of medication-naïve schizophrenics. Presented at the XXIVth CINP Congress, Paris, France June 20-24, 2004 (#P02.479).

 

• Mukherjee, J., Narayanan, T.K., Xue, B., Christian, B., Chattopadhyay, S., Shi, B., Pichika, R. and Collins, D.: Can internalization of high-affinity state of dopamine D2/D3 receptors be studied using fluorine-18 agonists? Presented at “The Fifth International Symposium on Functional Neuroreceptor Mapping of Living Brain”, University of British Columbia, Vancouver, Canada, July 15-18, 2004.

 

• Christian, B.T., Buchsbaum, M.S., Lehrer, D.S., Narayanan, T.K., Shi, B., Oakes, T.R., Mantil, J. and Mukherjee, J.: Statistical parametric mapping of ¹⁸F-fallypride binding in never medicated patients with schizophrenia. Presented at “The Fifth International Symposium on Functional Neuroreceptor Mapping of Living Brain”, University of British Columbia, Vancouver, Canada, July 15-18, 2004.

 

• Christian, B.T., Mukherjee, J., Shi, B., Narayanan, T.K., Lehrer, D.L. and Mantil, J.: Test-retest reliability of [C-11]fallypride for measuring dopamine D2/D3 receptor occupancy of clozapine. Presented at “The Fifth International Symposium on Functional Neuroreceptor Mapping of Living Brain”, University of British Columbia, Vancouver, Canada, July 15-18, 2004.

 

• Mukherjee, J., Pichika, R., Leslie, F.M., Christian, B.T., Xue, B., Chattopadhyay, S., Shi, B., Collins, D., Narayanan, T.K. and Potkin, S.G.: Design and development of novel new PET imaging agents for a4b2 nicotinic receptors: ¹⁸F-nifrolidine and ¹⁸F-nifzetidine. Presented at “The Fifth International Symposium on Functional Neuroreceptor Mapping of Living Brain”, University of British Columbia, Vancouver, Canada, July 15-18, 2004.

 

• Xue, B., Chattopadhyay, S. and Mukherjee, J.: Measure nicotine-induced dopamine release in rodent nucleus accumbens. Presented at The Society of Nuclear Medicine 50th Annual Meeting, June 21-25, 2003, New Orleans, LA ( Nucl. Med., 44: 229 suppl, 2003).

 

• Chattopadhyay, S., Bagnera, R., Leslie, F.M., Xue, B., Christian, B., Shi, B., Narayanan, T.K., Potkin, S.G. and Mukherjee, J.: ¹⁸F-Nifrolidine: PET imaging agent for 42 nicotinic receptors. Presented at The Society of Nuclear Medicine 50th Annual Meeting, June 21-25, 2003, New Orleans, LA ( Nucl. Med., 44: 606 suppl, 2003) (Chattopadhyay Awarded Certificate of Excellence by Indo-American Society of Nuclear Medicine).

 

• Chattopadhyay, S., Xue, B., Shi, B. and Mukherjee, J.: ¹⁸F-5-OH-FHXPAT: A new dopamine D2/D3 receptor agonist radiotracer. Presented at The Society of Nuclear Medicine 50th Annual Meeting, June 21-25, 2003, New Orleans, LA ( Nucl. Med., 44: 608 suppl, 2003).

 

• Christian, B.T., Shi, B., Chattopadhyay, S., Narayanan, T.K., Lehrer, D., Mantil, J. and Mukherjee, J.: In vivo kinetics of [C-11]fallypride: Effects of ligand mass on tracer kinetics in the thalamus. Presented at The Society of Nuclear Medicine 50th Annual Meeting, June 21-25, 2003, New Orleans, LA (Nucl. Med., 44: 811 suppl, 2003).

 

• Shi, B., Chattopadhyay, S., Christian, B.T., Narayanan, T.K., Mantil, J. and Mukherjee, J.: ¹¹C-Fallypride: A PET imaging agent for dopamine D2/D3 receptors. Presented at The Society of Nuclear Medicine 50th Annual Meeting, June 21-25, 2003, New Orleans, LA ( Nucl. Med., 44: 1051 suppl, 2003).

 

• Mukherjee, J., Xue, B., Chattopadhyay, S. and Leslie, F.M.: Imaging Nicotine-Induced Dopamine Release in Rodent Nucleus Accumbens.   Presented at The Society for Neuroscience 33rd Annual Meeting, New Orleans, LA November 8-12, 2003 (session #793.5).

 

• Chattopadhyay, S., Xue, B., Narayanan, T., Shi, B., Christian, B. and Mukherjee, J.:Internalization of high-affinity state of dopamine D2/D3 receptors using fluorine-18 agonists. Presented at The Society for Neuroscience 33rd Annual Meeting, New Orleans, LA November 8-12, 2003 (session # 363.11).
• Wang, C.S., Collins, D. and Mukherjee, J.: Fluorine-18 labeled benzazepines for imaging dopamine D-1 receptors. Label. Compd. Radiopharm., 48:S101, 2005. Presented at The16th International Symposium on Radiopharmaceutical Chemistry, Iowa City, Iowa, June 24-28, 2005.

 

• Halldin, C., Schou, M., Shchukin, E., Mukherjee, J., Chattopadhyay, S., Sovago, J., Gulyas, B. and Farde, L.: ¹¹C-Fallypride is an excellent PET tracer for both striatal and extrastriatal dopamine D2/D3 receptors. Presented at the “European Society of Nuclear Medicine“, Amsterdam, August 24-27, 2003.

 

• Potkin, S.G., Alva, G., Panagides, J., Carreon, D.T., Langstrom, B., Mukherjee, J., De Greef, R. and Bunney, W.E.: Predicting clinical antipsychotic doses from preclinical and PET studies: A case study with asenapine. Presented at the ACNP 42^nd Annual Meeting, San Juan, Puerto Rico, December 7-11, 2003.

 

• Chattopadhyay, S., Christian, B.T., Bagnera, R., Leslie, F.M., Xue, B., Shi, B., Narayanan, T.K., Potkin, S.G. and Mukherjee, J.: ¹⁸F-Nifrolidine: A new PET imaging agent for 42 nicotinic receptors. Presented at the “VI^th International Conference on Quantification of Brain Function with PET“, Calgary, Canada, July 1-3, 2003.

 

• Schou, M., Halldin, C., Shchukin, E., Mukherjee, J., Chattopadhyay, S., Sovago, J., Gulyas, B. and Farde, L.: Preparation and PET evaluation of ¹¹C-fallypride- for extrastriatal dopamine D2/D3 receptors. Presented at the 15th International Symposium on Radiopharmaceutical Chemistry, August 10-14, 2003, Sydney, Australia.

 

• Mukherjee, J., Christian, B.T., Shi, B., Narayanan, T.K. and Mantil, J: Comparison of ¹⁸F-fallypride displacement in the thalamus by nicotine-induced and amphetamine-induced dopamine release. Presented at Society of Nuclear Medicine 49th Annual Meeting, June 15-19, 2002, Los Angeles, CA.

 

• Shi, B., Narayanan, T.K., Mattmuller, S., Carone, M., Christian, B., Mukherjee, J. and Mantil, J.: Automated clinical production of fluorine-18 radiopharmaceuticals with electrophilic or nucleophilic substitution in a custom manufactured fluorination module. Presented at The Society of Nuclear Medicine 49th Annual Meeting, June 15-19, 2002, Los Angeles, CA.

 

• Christian, B.T., Mukherjee, J., Narayanan, T.K., Shi, B. and Mantil, J.: Quantitation of dopamine D-2 receptors in the thalamus of monkeys using a multiple injection protocol with ¹⁸F-fallypride and PET. Presented at The Society of Nuclear Medicine 49th Annual Meeting, June 15-19, 2002, Los Angeles, CA.

 

• Madakasira, P.V., Simkins, R., Christian, B., White, P., Mukherjee, J., Lee, C. and Mantil, J.: Clinical utility of 11C-flumazenil (FMZ) PET in intractable temporal lobe epilepsy. Presented at The Society of Nuclear Medicine 49th Annual Meeting, June 15-19, 2002, Los Angeles, CA.

 

• Mukherjee, J., Christian, B.T., Shi, B., Narayanan, T.K. and Mantil, J: ¹⁸F-Fallypride displacement in the nonhuman primate brain by nicotine-induced and amphetamine-induced dopamine release. Presented at “The Fourth International Symposium onFunctional Neuroreceptor Mapping of Living Brain”, Keble College, Oxford, UK, July 19-21, 2002.

 

• Christian, B.T., Mukherjee, J., Narayanan, T.K., Shi, B. and Mantil, J: Characterizing the in vivo binding parameters of ¹⁸F-fallypride in monkeys using a PET multiple-injection protocol. Presented at “The Fourth International Symposium on Functional Neuroreceptor Mapping of Living Brain”, Keble College, Oxford, UK, July 19-21, 2002.

 

• Chattopadhyay, S., Leslie, F.M., Potkin, S.G. and Mukherjee, J.: Design and synthesis of fluoroalkyl-pyridyl ethers as potential PET radioligands for 42 nicotinic acetylcholine receptors. Presented at The Society for Neuroscience 32nd Annual Meeting, Orlando, Florida, November 2-7, 2002 (session # 137.18).

 

• Saini, B.K., Christian, B.T., Andrews, R., Metz, J.T., Mukherjee, J. and Schlemmer, R.F.: Effects of haloperidol on regional cerebral metabolism of glucose and dopamine receptor occupancy using PET in the nonhuman primate. Presented at The Society for Neuroscience 32nd Annual Meeting, Orlando, Florida, November 2-7, 2002.

 

• Adinehzadeh, M., Poelstra, R., Jacob, M., Mantil, J., Mukherjee, J., Christian, B., Shi, B., Kent, M. and Ezzeddine, B.: Choline imaging with PET and 2D-CSI in a human brain astrocytoma. Presented at the International Society of Magnetic Resonance in Medicine, Glasgow, Scotland, April 21-27, 2001.

 

• Narayanan, T.K., Said, S., Mukherjee, J., Dunigan, K. and Mantil, J: Comparative study of radiolabeled fluorodeoxyglucose, methionine and choline in human astrocytoma. Presented at The Society of Nuclear Medicine 48th Annual Meeting, June 23-27, 2001, Toronto, Canada ( Nucl. Med., 42: 914 suppl, 2001).

 

• Shi, B., Narayanan, T.K., Matmuller, S., Carone, M. and Mukherjee, J.: Evaluation of automated production of carbon-11 radiopharmaceuticals in a tandem GE [C-11] CH3I synthesizer and NI [C-11] methylation module. Presented at The Society of Nuclear Medicine 48th Annual Meeting, June 23-27, 2001, Toronto, Canada ( Nucl. Med., 42: 1121 suppl, 2001).

 

• Mukherjee, J., Christian, B., Narayanan, T., Shi, B., Dunigan, K., Satter, M. and Mantil, J.: Imaging dopamine receptors using ¹⁸F-fallypride in normal volunteers. Presented at the Society for Neuroscience 31st Annual Meeting, San Diego, California, November 10-15, 2001 (Soc. Neurosci. Abstr., 27: 811.19, 2001).

 

• Christian, B., Narayanan, T., Shi, B., Metz, J. and Mukherjee, J.: Amphetamine-induced displacement of ¹⁸F-fallypride in the thalamus in monkey PET studies.Presented at the Society for Neuroscience 31st Annual Meeting, San Diego, California, Nov. 10-15, 2001 (Soc. Neurosci. Abstr., 27: 774.4, 2001).

 

• Christian, B.T., Narayanan, T.K., Shi, B. and Mukherjee, J.,: The measurement of dopamine D-2 binding of atypical neuroleptics with ¹⁸F-fallypride PET imaging. Presented at The Society of Nuclear Medicine 47th Annual Meeting, June 6-10, 2000, St. Louis, MO ( Nucl. Med., 41: 101 suppl, 2000).

 

• Shi, B., Narayanan, T.K., Christian, B.T. and Mukherjee, J.: Radiosynthesis and evaluation of ¹⁸F-5-OH-FPPAT as an agonist for the dopamine D-2 receptor. Presented at The Society of Nuclear Medicine 47th Annual Meeting, June 6-10, 2000, St. Louis, MO ( Nucl. Med., 41: 481 suppl, 2000).

 

• Mukherjee, J., Narayanan, T.K., Shi, B. and Christian, B.T.: Interaction of clozapine with dopamine D-2 receptors in rodents and monkeys using ¹⁸F-fallypride. Presented at The Society of Nuclear Medicine 47th Annual Meeting, June 6-10, 2000, St. Louis, MO ( Nucl. Med., 41: 264 suppl, 2000).

 

• Mukherjee, J., Christian, B.T., Shi, B. and Narayanan, T.K.: Comparison of dopamine D-2 receptor agonists, ¹¹C-5-OH-DPAT, ¹¹C-PPHT, ¹¹C-ZYY339 and ¹⁸F-5-OH-FPPAT as in vivo imaging agents for PET. Presented at The Society of Nuclear Medicine 47th Annual Meeting, June 6-10, 2000, St. Louis, MO ( Nucl. Med., 41: 94 suppl, 2000).

 

• Mukherjee, J., Christian, B.T., Narayanan, T.K., Shi, B. and Mantil, J.: Measurement of Striatal and Extrastriatal D-2 Receptor Occupancy by Clozapine and Risperidone using [¹⁸F]Fallypride and PET. Presented at “The Third International Symposium on Functional Neuroreceptor Mapping of Living Brain”, New York City, New York, June 9-11, 2000.

 

• Mukherjee, J., Shi, B., Narayanan, T.K., Christian, B.T., and Mantil, J: Development and Evaluation of Dopamine D-2 Receptor Agonists for In Vivo Imaging Using PET. Presented at “The Third International Symposium on Functional Neuroreceptor Mapping of Living Brain”, New York City, New York, June 9-11, 2000.

 

• Christian, B.T., Mukherjee, J., Narayanan, T.K., Shi, B. and Mantil, J: PET imaging and quantitation of [¹⁸F]fallypride in Macauque monkeys. Presented at “The Third International Symposium on Functional Neuroreceptor Mapping of Living Brain”, New York City, New York, June 9-11, 2000.

 

• Roberts, A.D., DeJesus, O.T., Schneider, M.L., Schueller, M.J., Shelton, S.E., Mukherjee, J. and Nickles, R.J.: Dopamine system characterization of rhesus monkeys exposed in utero to moderate dose of alcohol. Presented at The Society of Nuclear Medicine 46th Annual Meeting, June 6-10, 1999, Los Angeles, California ( Nucl.Med., 40: 108P, 1999).

 

• Mukherjee, J., Shi, B. and Narayanan, T.K.: Evaluation of dopamine D-2 receptor agonists, ¹¹C-ZYY-339 and ¹¹C-PPHT as potential in vivo imaging agents. Presented at The Society of Nuclear Medicine 46th Annual Meeting, June 6-10, 1999, Los Angeles, California ( Nucl.Med., 40: 304P, 1999).

 

• Christian, B.T., Mukherjee, J., Shi, B. and Narayanan, T.K.: Using parametric images of [F-18] fallypride to measure striatal and nonstriatal binding. Presented at The Society of Nuclear Medicine 46th Annual Meeting, June 6-10, 1999, Los Angeles, California ( Nucl.Med., 40: 287P, 1999).

 

• Mukherjee, J., Shi, B., Narayanan, T.K. and Yang, Z.Y.: “Radiopharmaceuticals for Imaging the Brain”. Presented at the symposium on “Future of Nuclear Medicine Physics and Instrumentation”, Chicago, IL., March 19-21, 1999.

 

• Shi, B., Narayanan, T.K., Yang, Z.Y. and Mukherjee, J.: Radiosynthesis and in vitro evaluation of 2-(N-alkyl-N-1-¹¹C-propyl)-aminotetralin analogs as high affinity agonists for dopamine D-2 receptors. Presented at the XIIIth International Symposium on Radiopharmaceutical Chemistry, St. Louis, MO., June 27 to July 1, 1999 ( Label. Compds. Radiopharm., 42:S384-S386, 1999).

 

• Mukherjee, J., Narayanan, T.K., Shi, B. and Christian, B.T.: Evaluation of dopamine D-2 receptor occupancy in vitro by clozapine in rodents using ¹⁸F-fallypride. Presented at the Society for Neuroscience 29th Annual Meeting, Miami Beach, Florida, October 23-28, 1999.

 

• Mukherjee, J. and Yang, Z-Y.: Monoamine oxidase inhibition in vivo by fluoxetine. Presented at The Society of Nuclear Medicine 45th Annual Meeting, June 7-11, 1998, Toronto, Canada ( Nucl. Med., 39: 41P, 1998).

 

• Mukherjee, J. and Yang, Z-Y.: N-(6-[F-18]fluorohexyl)-N-methylpropargylamine: A PET radiotracer for monoamine oxidase B. Presented at The Society of Nuclear Medicine 45th Annual Meeting, June 7-11, 1998, Toronto, Canada ( Nucl. Med., 39: 231P, 1998).

 

• Christian, B., Mukherjee, J., Cooper, M., Adityanjee, Morris, E., Satter, M. and Mantil, J.: Specific binding of [F-18]fallypride and [F-18]desmethoxyfallypride in Macaque monkeys. Presented at The Society of Nuclear Medicine 45th Annual Meeting, June 7-11, 1998, Toronto, Canada ( Nucl. Med., 39: 207P, 1998).

 

• Satter, MR., Poelstra, R., Kraus, G., Berstein, T., Gillum, T., Ezzedine, B., Hwang, D-R., Dunigan, K., Gagermeier, E., Christian, B., Mukherjee, J., Mantil, J.: Utility of PET data in image-guided neurosurgery and X-knife. Presented at The Society of Nuclear Medicine 45th Annual Meeting, June 7-11, 1998, Toronto, Canada ( Nucl. Med., 39: 214P, 1998).

 

• Mukherjee, J.: In vivo competition of dopamine with antagonists: A hypothesis for fallypride and raclopride. Presented at “The Second International Symposium on Functional Neuroreceptor Mapping of Living Brain”, Ann Arbor, Michigan, June 12-14, 1998 (Neuroimage, 7(4):A9, 1998).

 

• Mukherjee, J., Shi, B. and Yang, Z-Y.: Development of dopamine D-2 receptor agonists as potential in vivo imaging agents for PET. Presented at the Society for Neuroscience 28th Annual Meeting, Los Angeles, CA., November 7-12, 1998 (Session 340.2).

 

• Pan, X., La Riviere, P.J., Ye, J., Mukherjee, J. and Chen, C.T.: Efficient sinogram smoothing for dynamic neuroreceptor PET imaging. Presented at the SPIE Medical Imaging Symposium, Newport Beach, California, February 22-28, 1997.

 

• Kovar, D.A., Mukherjee, J., Lewis, M.Z., Lipton, M.J. and Karczmar, G.S.: Uptake kinetics of a new rapidly extracted gadolinium-chelate. Presented at the International Society of Magnetic Resonance in Medicine, 1997, Vancouver, Canada.

 

• Mukherjee, J., Das, M., Yang, Z-Y., Brown, T., Lew, R., Cook, E. Jr. and Cooper, M.: Is monoamine oxidase inhibition involved in the therapeutic effects of Prozac? Presented at The Society of Nuclear Medicine 44th Annual Meeting, June 2-5, 1997, San Antonio, Texas ( Nucl. Med., 38: 284P, 1997).

 

• Mukherjee, J. and Yang, Z-Y.: Evaluation of monoamine oxidase B inhibition by Prozac. Presented at the Society for Neuroscience 27th Annual Meeting, New Orleans, LA., October 25-30, 1997 ( Neurosci. Abstr., 23: 1997; abstract #435.4).

 

• Yang, Z-Y. and Mukherjee, J.: Paradoxical effects of the N-cyclopropylmethyl group in substituted benzamides: design of potential dopamine D-3 receptor agents. Presented at the Society of Nuclear Medicine 43rd Annual Meeting, June 3-6, 1996, Denver, Colorado ( Nucl. Med., 37: 193P, 1996).

 

• Mukherjee, J. and Yang, Z-Y.: [F-18]Fluorinated substituted benzamide analog of YM-43611 as a potential radiotracer for dopamine D-4 receptors. Presented at the Society of Nuclear Medicine 43rd Annual Meeting, June 3-6, 1996, Denver, Colorado ( Nucl. Med., 37: 50P, 1996).

 

• Blend, M.J., Friedman, M., O’Dowd, T., Tantayakom, S., Rubas, B., Levi, H., Penny, B.C. and Mukherjee, J.: Improved flood source uniformity using chelation of In-111 in a liquid filled plexiglass tank. Presented at the Society of Nuclear Medicine 43rd Annual Meeting, June 3-6, 1996, Denver, Colorado ( Nucl. Med., 37: 211P, 1996).

 

• Mukherjee, J., Yang, Z.Y., Brown, T., Roemer, J. and Cooper, M.: Evaluation of extrastriatal dopamine receptors by using [F-18]fallypride. Presented at the Society for Neuroscience 26th Annual Meeting, Washington D.C., November 16-21, 1996 ( Neurosci. Abstr., 22: 498, 1996; abstract #202.6).

 

• Wernick, M.N., Wang, G., Kao, C-M., Yap, J.T., Mukherjee, J., Cooper, M. and Chen, C.T.: Reconstruction methods for dynamic PET image sequences. Presented at the IEEE Nuclear Science Symposium and Medical Imaging Conference San Francisco, USA, October 21-28, 1995 (IEEE 1995 Nuclear Science Symposium and Medical Imaging Conference Record , 3:1718-1722, 1996).

 

• Kovar, D.A., Mukherjee, J., Lewis, M.Z., Lipton, M.J. and Karczmar, G.S.: Uptake kinetics of a new highly permeable gadolinium-chelate. Presented at The Radiological Society of North America 82nd Annual Meeting, December 1-6, 1996, Chicago, Illinois (Radiology, 201:1419, Suppl. S. 1996).

 

• Mukherjee, J., Yang, Z-Y., Brown, T. and Cooper, M.: Evaluation of a dose-response curve of d-amphetamine as a function of change in [F-18]fallypride binding at dopamine receptors. Presented at The Society of Nuclear Medicine 42nd Annual Meeting, June 12-15, 1995, Minneapolis, MN ( Nucl. Med., 36:255P, 1995).

 

• Yang, Z-Y. and Mukherjee, J.: Development of agonists as radiotracers for the assessment of the functional state of dopamine D-2 receptors. Presented at The Society of Nuclear Medicine 42nd Annual Meeting, June 12-15, 1995, Minneapolis, MN ( Nucl. Med., 36:152P, 1995).

 

• Ouyang, X., Yang, Z-Y. and Mukherjee, J.: Towards a positron-radiotracer for the ionophore associated with the NMDA receptor. Presented at The Society of Nuclear Medicine 42nd Annual Meeting, June 12-15, 1995, Minneapolis, MN ( Nucl. Med., 36:150P, 1995).

 

• Yang, Z-Y and Mukherjee, J.: Development of Fluorinated Dopamine Receptor Agonists as Potential Radiotracers for Functional Assessment of the Receptors. Presented at the XIth International Symposium on Radiopharmaceutical Chemistry, Vancouver, Canada, August 13-17, 1995 ( Label. Compds. Radiopharm., 37:6-7, 1995).

 

• Mukherjee, J., Yang, Z-Y., Brown, T., Ouyang, X and Cooper, M.: Biodistribution Study of the Dopamine D-2 Receptor PET Radiotracer, ¹⁸F-Fallypride. Presented at the XIth International Symposium on Radiopharmaceutical Chemistry, Vancouver, Canada, August 13-17, 1995 ( Label. Compds. Radiopharm., 37:8-9, 1995).

 

• Mukherjee, J., Yang, Z-Y., Brown, T., Roemer, J. and Cooper, M.: Evaluation of d-amphetamine effects on dopamine D-2 receptor radiotracers, [F-18]fallypride and [F-18]desmethoxyfallypride. Presented at The Society of Nuclear Medicine 41st Annual Meeting, June 5-8, 1994, Orlando, Florida. ( Nucl. Med., 35:139P, 1994).

 

• Mukherjee, J. and Yang, Z-Y.: Is quaternary piperazine N-oxide an aromatic ring activator for nucleophilic substitution reactions with [F-18]fluoride? Presented at The Society of Nuclear Medicine 41st Annual Meeting, June 5-8, 1994, Orlando, Florida ( Nucl. Med., 35:252P, 1994).

 

• Mukherjee, J. and Kapp, O.H.: Selective radiotracers for imaging dopamine D-2 receptors by PET: Molecular nature of receptor radiotracer interaction. Presented at the 41st Annual Meeting of the Association of University Radiologists, Cincinnati, May 19-23, 1993 ( Radiology, 28:1214, 1993).

 

• Kapp, O.H. and Mukherjee, J.: Protein modeling using homology: Implications in nuclear medicine imaging. Presented at the 41st Annual Meeting of the Association of University Radiologists, Cincinnati, May 19-23, 1993 ( Radiology, 28:1212, 1993).

 

• Mukherjee, J., Yang, Z.Y., Das, M.K., Kronmal, S., Brown, T. and Cooper, M.: [F-18]fallypride as an improved PET radiotracer for dopamine D-2 receptors. Presented at The Society of Nuclear Medicine 40th Annual Meeting, June 8-11, 1993, Toronto, Canada ( Nucl. Med., 34:243P, 1993).

 

• Mukherjee, J., Das, M.K., Yang, Z.Y., Lew, R and Cooper, M.: Analysis of [F-18]fluoxetine as a potential marker for serotonin uptake sites. Presented at The Society of Nuclear Medicine 40th Annual Meeting, June 8-11, 1993, Toronto, Canada ( Nucl. Med., 34:239P, 1993).

 

• Das, M.K. and Mukherjee, J.: [F-18]RP 62203: A high affinity and selective radioligand as a potential PET tracer for serotonin 5HT2 receptor. Presented at the Xth International Symposium on Radiopharmaceutical Chemistry, Kyoto, Japan, October 25-28, 1993 ( Label. Compds. Radiopharm. 35:497-499, 1994).

 

• Yang, Z.Y. and Mukherjee, J.: In vivo evaluation of fluorinated benzazepines as selective, high affinity PET tracers for dopamine D-1 receptors. Presented at the Xth International Symposium on Radiopharmaceutical Chemistry, Kyoto, Japan, October 25-28, 1993 ( Label. Compds. Radiopharm. 35:427-429, 1994).

 

• Mukherjee, J., Ouyang, X-H. and Yang, Z.Y.: [F-18]Fluorine labeled TCP-derivatives for the NMDA receptor-linked calcium ionophore. Presented at the Xth International Symposium on Radiopharmaceutical Chemistry, Kyoto, Japan, October 25-28, 1993 ( Label. Compds. Radiopharm. 35:504-506, 1994).

 

• Mukherjee, J., Yang, Z.Y., Perry, B.D. and Cooper, M.: [F-18]fluorinated derivatives of SCH 38548 as potential PET radiotracers for dopamine D-1 receptors. Presented at the 40th Annual Meeting of the Association of University Radiologists, Chicago, Illinois, April 22-26, 1992 (Invest. Radiol, 27:1120, 1992).

 

• Mukherjee, J., Yang, Z.Y., Perry, B.D. and Cooper, M.: High affinity and selective [F-18]fluorinated derivatives of SCH 38548 as potential PET radiotracers for dopamine D-1 receptors. Presented at the The Society of Nuclear Medicine 39th Annual Meeting, June 9-12, 1992, Los Angeles, California ( Nucl. Med. 33:829, 1992).

 

• Fang, Y-B., Mukherjee, J., Yang, Z.Y. and Cooper, M.: Alternate Syntheses of [125I]-Ioxipride and [125I]-Epidepride: High Affinity and Selective Dopamine D-2 Receptor Radioligands. Presented at the The Society of Nuclear Medicine 39th Annual Meeting, June 9-12, 1992, Los Angeles, California (Nucl. Med. 33:982, 1992).

 

• Mukherjee, J., Yang, Z.-Y. and Cooper, M.: Syntheses, Pharmacological and lipophilicity studies of improved analogs of the D-2 PET tracer, [F-18]FPMB. Presented at The Sixth Symposium on the Application of Cyclotrons, Turku, Finland, June 1-4, 1992 ( Univ. Turkuensis, 88: A59-60, 1992).

 

• Mukherjee, J., Yang, Z.Y., Perry, B.D. and Cooper, M.: Fluorine-18 derivatives of 7-chloro-8-hydroxy-3-methyl-1-(3′-aminophenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH 38548): Selective and high affinity fluorinated radioligands for dopamine D-1 receptors. Presented at the IXth International Symposium on Radiopharmaceutical Chemistry, Paris, April 6-10, 1992 ( Label. Compds.Radiopharm. 32:120-122, 1993).

 

• Fang, Y.-B., Mukherjee, J. and Cooper, M.: Alternate Syntheses [125I]Ioxipride and [125I]-Epidepride: High Affinity and Selective Dopamine D-2 Receptor Radioligands. Presented at the IXth International Symposium on Radiopharmaceutical Chemistry, Paris, April 6-10, 1992 ( Label. Compds. Radiopharm. 32:234-236, 1993).

 

• Mukherjee, J., Perry, B.D. and Cooper, M.: Development of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-([F-18]fluoroalkyl)-3-substituted-2-methoxybenzamides as potential dopamine D-2 radiotracers for PET. Presented at the 8thInternational Symposium in Radioph armaceutical Chemistry, Princeton, New Jersey, June 24-29, 1990 ( Label. Compds. Radiopharm. 30:380-381, 1991).

 

• Murphy, S.N., Mukherjee, J., Luh, K.E., Dowd, M. and Cooper, M.: Estimation of dopamine D-2 receptors in cebus apella using [F-18]FPMB. Presented at the XV International Symposium on Cerebral Blood Flow and Metabolism, BRAIN-91, June 1-6, 1991, Miami, Florida ( Cereb. Blood Flow Metab. 11:S602, 1991).

 

• Murphy, S.N., Dowd, M.T., Mukherjee, J. and Cooper, M.: Failure of compartmental models with high affinity receptors due to diffusion gradients. Presented at the The Society of Nuclear Medicine 38th Annual Meeting, June 11-14, 1991, Cincinnati, Ohio ( Nucl. Med. 32:1060, 1991).

 

• Mukherjee, J., Luh, K.E., Yasillo, N., Perry, B.D., Levy, D., Chen, C.-T, Ortega, C., Chou, J-S. and Cooper, M.D.: Dopamine D-2 receptors imaged by PET in cebus apella with (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(3[F-18]-fluoropropyl)-2,3-dimethoxybenzamide. Presented at The Society of Nuclear Medicine 37th Annual Meeting, June 19-22, 1990, Washington, D.C. ( Nucl. Med. 31:787,1990).

 

• Mukherjee, J., Yasillo, N.J., Luh, K.E., Diamond, M., Levy, D., Chen, C-T. and Cooper, M.: Imaging dopamine D-2 receptors in Cebus apella by PET using [F-18]fluoropropylspiperone and [F-18]fluorinated benzamide neuroleptic. Presented at The Radiological Society of North America 76th Annual Meeting, November 25-30, 1990, Chicago, Illinois (Radiology, 177(P):235, 1990).

 

• DeJesus, O.T., Chen, C.A., Mukherjee, J. and Khalifah, R.G.: Synthesis and evaluation of Br-75-6-bromo-m-tyrosine as tracer for CNS dopamine. Presented at the The Society of Nuclear Medicine 36th Annual Meeting, June 13-16, 1989, St. Louis, Missouri (J Nucl. Med. 30:924, 1989).

 

• DeJesus, O.T., Sunderland, J.J., Chen, C.A., Nickles, R.J., Mukherjee, J. and Appelman, E.H.: Synthesis of radiofluorinated analogs as potential L-DOPA PET tracers. Presented at the The Society of Nuclear Medicine 36th Annual Meeting, June 13-16, 1989, St. Louis, Missouri (J Nucl. Med. 30:930, 1989).

 

• DeJesus, O.T., Mukherjee, J. and Appelman, E.H.: Synthesis of ortho- and meta-tyrosine analogs as potential tracers for CNS dopamine. Presented at the VIIth International Symposium in RadiopharmaceuticalnChemistry, Groningen, Netherlands, July 4-8, 1988. ( Label. Compds. Radiopharm. 27:133-134,1989).

 

• Mukherjee, J., Murphy, S.N., Hartwig, W., Miller, R.J. and Cooper, M.D.: N-(3-F-18 Fluoropropyl) MK-801: A PET tracer for in-vivo studies of the N-methyl-D-aspartate receptors. Presented at the The Society of Nuclear Medicine 35th Annual Meeting, June 14-17, 1988, San Francisco, California (J Nucl. Med. 29:932, 1988).